Overview

Slingshot Biosciences develops and sells synthetic cells for drug discovery, clinical trials, medical testing, and cell therapy manufacturing. These standardized cells are offered on-demand or made-to-order, providing researchers with consistent, controllable materials that replace traditional biological materials to improve data reliability. The company differentiates itself by delivering standardized, customizable, and readily available synthetic cells that reduce variability, with a North American customer focus and emphasis on sustainability. Its goal is to make healthcare more accessible and equitable globally by enabling reliable research and development across biopharma and healthcare.